Organization
David Williams
5 clinical trials
Clinical trial
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan ConditioningStatus: Active (not recruiting), Estimated PCD: 2025-10-01
Clinical trial
Multi-site Phase I/II Trial Evaluating the Treatment of SCID-X1 Patients With Retrovirus-mediated Gene TransferStatus: Completed, Estimated PCD: 2023-03-01
Clinical trial
Pilot and Feasibility Study of Hematopoietic Stem Cell Gene Transfer for the Wiskott-Aldrich SyndromeStatus: Active (not recruiting), Estimated PCD: 2024-07-01
Clinical trial
Pilot and Feasibility Study of Hematopoietic Stem Cell Gene Transfer for Sickle Cell DiseaseStatus: Active (not recruiting), Estimated PCD: 2024-05-13
Clinical trial
A Multi-Center, Phase 2 Gene Transfer Study Inducing Fetal Hemoglobin in Sickle Cell (GRASP, BMT CTN 2001)Status: Recruiting, Estimated PCD: 2026-05-01